MedTrace Logo

Parkinson's Disease Genetics Database

NCT00855556 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2015-09-16

No results posted yet for this study

Summary

The goal of the study is to develop and organize an effort to identify genes that determine an individual's risk for developing Parkinson's disease (PD).

1. To ascertain, study and establish a repository of DNA samples that will allow for the identification of known and yet-to-be-identified genetic markers associated with the development of PD.
2. To create a database with clinical, genetic (HLA, genome screen) and medical history information that will facilitate the search for PD susceptibility genes.
3. To provide a centralized DNA repository to allow for targeted studies of genetic factors contributing to the onset, heterogeneity and progression of PD.
4. To evaluate opportunities to extend the results of research to develop methods of risk prediction, prevention and therapy for PD.

Conditions

Interventions

GENETIC

blood draw

The blood collection is designed to obtain blood samples as a source of DNA for genotyping and to establish a plasma and serum storage repository for future assays. GCRC nurses will perform all blood draws associated with this study. The following procedures are designed to standardize sample collection: 1. Blood will be collected with the participant in the seated position with the reclining position reserved for those with a history of fainting during blood collection. 2. Participants will be instructed to drink plenty of water (e.g., at least 8 large glasses of water) prior to the clinic visit as this facilitates easier collection. 3. No fasting, activity or medication restrictions are required prior to or following blood collection. 4. Blood collection will follow completion of the questionnaires. They will be performed by a nurse or technician with documented class time and experience in phlebotomy. Technician certification will occur prior to blood collection.

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Michael Pourfar, MD · Northwell Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00855556 on ClinicalTrials.gov